STOCK TITAN
  1. Home
  2. Sec-filings
  3. GOVX
  4. [EFFECT] GeoVax Labs, Inc. SEC Filing

[EFFECT] GeoVax Labs, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 19, 2025 9:00 A.M.
Form: S-1
CIK: 0000832489
Company Name: GeoVax Labs, Inc.
File Number: 333-292127

Source: View Original Filing on SEC EDGAR

Stock GOVX logo
Geovax Labs Inc

NASDAQ:GOVX

GOVX Rankings

#6593 Ranked by Market Cap
N/A Ranked by Dividends
#38 Top Loser

GOVX Latest News

Dec 9, 2024
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
Nov 26, 2024
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
Nov 19, 2024
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
Nov 12, 2024
GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 5, 2024
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GOVX Latest SEC Filings

Dec 12, 2025
[S-1] GeoVax Labs, Inc. Files IPO Registration Statement
Nov 26, 2025
[8-K] GeoVax Labs, Inc. Reports Material Event
Nov 13, 2025
[8-K] GeoVax Labs, Inc. Reports Material Event
Nov 13, 2025
[424B3] GeoVax Labs, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Nov 13, 2025
[424B3] GeoVax Labs, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)

GOVX Stock Data

5.18M
29.55M
6.07%
12.73%
16.05%
Biotechnology
Pharmaceutical Preparations
Link
United States
SMYRNA